ASCO: Experimental targeted therapy improves progression-free survival for advan...
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
17 Jun 2009
Oestrogen and progestin therapy increases NSCLC risk
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
17 Jun 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
14 May 2009
AACR 2009: Genetics of pleuropulmonary blastoma
Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical C...
1 May 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
31 Mar 2009
COSMOS lung cancer study
Dr Giulia Veronesi - Deputy Director of the Division of Thoracic Surgery at the ...
18 Mar 2009
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
ECCO-ESMO Roundtable discussion - Full Version
16 Feb 2009
EORTC President
Prof. Martine Piccart
3 Dec 2008
Spanish Lung Cancer Group
Prof. Rafael Rosel
3 Dec 2008
Cornell University, New York
Prof. Nasser Altorki
3 Dec 2008
Chinese University, Hong Kong
Prof. Tony Mok
3 Dec 2008
